Drug discovery technology startup DyNAbind secures seed financing

Drug discovery technology start-up DyNAbind secures seed financing

DyNAbind’s Dynamic DNA-Encoded Library technology platform allows hundreds of millions of chemical structures to be simultaneously screened and optimized against a potential drug target protein. This innovation continues to be driven forward with investment from the High-Tech Gründerfonds (HTGF), Te...

Original Article: Drug discovery technology start-up DyNAbind secures seed financing

More From BioPortfolio on "Drug discovery technology start-up DyNAbind secures seed financing"